🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
The scientific name of meningococcus is Neisseria meningitidis (Nm), the ca...
Status
Completed
Location
Shanyang County Center for Disease Prevention and Control
Start Date
2023-09-16
Trial ID
NCT06011200
Primary Objective: To demonstrate sufficiency of the vaccine seroresponse ...
Status
Completed
Location
Investigational Site Number 8400026
Start Date
2019-10-04
Trial ID
NCT04142242
The purpose of this study is to evaluate the immunogenicity and safety of G...
Status
Unknown
Location
Hunan Center for Disease Control and Prevention
Start Date
2021-12-10
Trial ID
NCT06314685
This study was designed to evaluate the antibody response to a Menactra® bo...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT00777790
This study will be conducted among children in Saudi Arabia who previously ...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00539032
The clinical trial was designed to evaluate the safety and immunogenicity a...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT01661738
Treatments Being Tested
Safety and immunogenicity of meningococcal ACWY conjugate versus polysaccha...
Status
Completed
Location
FUNCEI, French 3085
Start Date
2006-05
Trial ID
NCT00329849
Treatments Being Tested
The goal of this clinical trial is to evaluate the immunogenicity and safet...
Status
Active Not Recruiting
Location
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Start Date
2026-03-22
Trial ID
NCT07505888
Treatments Being Tested
This study is a randomized, double-blinded, and controlled phase III clinic...
Status
Unknown
Location
Yunnan Center for Disease Control and Prevention
Start Date
2020-09-15
Trial ID
NCT04689191